Khajavi, N.* ; Beck, A.* ; Ricku, K.* ; Beyerle, P.* ; Jacob, K.* ; Syamsul, S.F.* ; Belkacemi, A.* ; Reinach, P.S.* ; Schreier, P.C.* ; Salah, H.* ; Popp, T.* ; Novikoff, A. ; Breit, A.* ; Chubanov, V.* ; Müller, T.D. ; Zierler, S.* ; Gudermann, T.*
TRPM7 kinase is required for insulin production and compensatory islet responses during obesity.
JCI insight 8:e163397 (2023)
Most overweight individuals do not develop diabetes due to compensatory islet responses to restore glucose homeostasis. Therefore, regulatory pathways that promote β-cell compensation are potential targets for treatment of diabetes. The melastatin transient receptor potential 7 protein (TRPM7), harboring a cation channel and a serine/threonine kinase, has been implicated in controlling cell growth and proliferation. Here, we report that selective deletion of Trpm7 in β-cells disrupts insulin secretion and leads to progressive glucose intolerance. We indicate that the diminished insulinotropic response in β-cell-specific Trpm7 knockout mice is caused by decreased insulin production due to an impaired enzymatic activity of this protein. Accordingly, high-fat fed mice with a genetic loss of TRPM7 kinase activity (Trpm7R/R) display a marked glucose intolerance accompanied by hyperglycemia. These detrimental glucoregulatory effects are engendered by reduced compensatory β-cell responses due to mitigated AKT/ERK signaling. Collectively, our data identify TRPM7 kinase as a novel regulator of insulin synthesis, β-cell dynamics, and glucose homeostasis under obesogenic diet.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
Publikationstyp
Artikel: Journalartikel
Dokumenttyp
Wissenschaftlicher Artikel
Typ der Hochschulschrift
Herausgeber
Schlagwörter
Beta Cells ; Cell Biology ; Insulin ; Ion Channels; Beta-cell-proliferation; Transcription Factor; Mass Expansion; Expression; Channels; Pdx1; Magnesium; Transactivator; Contributes; Hyperplasia
Keywords plus
Sprache
englisch
Veröffentlichungsjahr
2023
Prepublished im Jahr
2022
HGF-Berichtsjahr
2022
ISSN (print) / ISBN
2379-3708
e-ISSN
2379-3708
ISBN
Bandtitel
Konferenztitel
Konferzenzdatum
Konferenzort
Konferenzband
Quellenangaben
Band: 8,
Heft: 3,
Seiten: ,
Artikelnummer: e163397
Supplement: ,
Reihe
Verlag
Clarivate
Verlagsort
Ann Arbor, Michigan
Tag d. mündl. Prüfung
0000-00-00
Betreuer
Gutachter
Prüfer
Topic
Hochschule
Hochschulort
Fakultät
Veröffentlichungsdatum
0000-00-00
Anmeldedatum
0000-00-00
Anmelder/Inhaber
weitere Inhaber
Anmeldeland
Priorität
Begutachtungsstatus
Peer reviewed
POF Topic(s)
30201 - Metabolic Health
90000 - German Center for Diabetes Research
Forschungsfeld(er)
Helmholtz Diabetes Center
PSP-Element(e)
G-502200-001
G-501900-221
Förderungen
DFG
DZD
Deutsche Forschungsgemeinschaft (German Research Foundation, DFG)
Copyright
Erfassungsdatum
2023-01-10